Index Catalog // ScholarsArchive@OSU

Creator:: Odden, Michelle C., Yee, Laura M., Arnold, Alice M., Sanders, Jason L., Hirsch, Calvin, deFilippi, Christopher, Kizer, Jorge R., Inzitari, Marco, and Newman, Anne B.
Abstract:: OBJECTIVES: Subclinical vascular disease (SVD) contributes to the aging process and may decrease life expectancy. We aimed to determine the contribution of gradations of SVD to the likelihood of achieving longer survival, and to determine what allows some individuals to achieve longer survival in the presence of high SVD. DESIGN:...

Creator:: Odden, Michelle C., Yee, Laura M., Arnold, Alice M., Sanders, Jason L., Hirsch, Calvin, deFilippi, Christopher, Kizer, Jorge R., Inzitari, Marco, and Newman, Anne B.
Abstract:: OBJECTIVES: Subclinical vascular disease (SVD) contributes to the aging process and may decrease life expectancy. We aimed to determine the contribution of gradations of SVD to the likelihood of achieving longer survival, and to determine what allows some individuals to achieve longer survival in the presence of high SVD. DESIGN:...

Creator:: Moran, Andrew E., Odden, Michelle C., Thanataveerat, Anusorn, and et al.
Abstract:: BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and monitoring costs, costs...

Creator:: Moran, Andrew E., Odden, Michelle C., Thanataveerat, Anusorn, and et al.
Abstract:: BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and monitoring costs, costs...

Creator:: Moran, Andrew E., Odden, Michelle C., Thanataveerat, Anusorn, and et al.
Abstract:: BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and monitoring costs, costs...

Creator:: Peralta, Carmen A., McClure, Leslie A., Scherzer, Rebecca, Odden, Michelle C., White, Carole L., Shlipak, Michael, Benavente, Oscar, and Pergola, Pablo
Abstract:: Background—The effect of intensive blood pressure (BP) lowering on kidney function among individuals with established cerebrovascular disease and preserved estimated glomerular filtration rate (eGFR) is not established. Methods and Results—Among 2610 participants randomized to a lower (<130 mm Hg) versus higher (130–149 mm Hg) systolic BP target with repeated measures...

Creator:: Peralta, Carmen A., McClure, Leslie A., Scherzer, Rebecca, Odden, Michelle C., White, Carole L., Shlipak, Michael, Benavente, Oscar, and Pergola, Pablo
Abstract:: Background—The effect of intensive blood pressure (BP) lowering on kidney function among individuals with established cerebrovascular disease and preserved estimated glomerular filtration rate (eGFR) is not established. Methods and Results—Among 2610 participants randomized to a lower (<130 mm Hg) versus higher (130–149 mm Hg) systolic BP target with repeated measures...

Creator:: Odden, Michelle C., Shlipak, Michael G., Whitson, Heather E., and et al.
Abstract:: OBJECTIVE: The associations of some risk factors with cardiovascular disease (CVD) are attenuated in older age; whereas others appear robust. The present study aimed to compare CVD risk factors across older age. METHODS: Participants (n = 4883) in the Cardiovascular Health Study free of prevalent CVD, were stratified into three...

Creator:: Odden, Michelle C., Shlipak, Michael G., Whitson, Heather E., and et al.
Abstract:: OBJECTIVE: The associations of some risk factors with cardiovascular disease (CVD) are attenuated in older age; whereas others appear robust. The present study aimed to compare CVD risk factors across older age. METHODS: Participants (n = 4883) in the Cardiovascular Health Study free of prevalent CVD, were stratified into three...

ScholarsArchive@OSU